Literature DB >> 17063497

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Christopher J Gannon1, Dennis L Rousseau, Merrick I Ross, Marcella M Johnson, Jeffrey E Lee, Paul F Mansfield, Janice N Cormier, Victor G Prieto, Jeffrey E Gershenwald.   

Abstract

BACKGROUND: Sentinel lymph node (SLN) status is the most important prognostic factor with respect to the survival of patients with primary cutaneous melanoma. However, lymphatic mapping and SLN biopsies (LM/SLNBs) performed in patients who have had a wide local excision (WLE) may not accurately reflect the pathologic status of the draining lymph node basins. The purpose of this study was to assess the feasibility and accuracy of LM/SLNB in patients who have had a previous WLE.
METHODS: A single-institution database was examined to identify patients who had a WLE before LM/SLNB and patients who had a concomitant LM/SLNB. Primary clinicopathologic features (age, tumor thickness, and ulceration), SLN identification rate, SLN pathologic status, and the incidence and sites of recurrences were compared between patients with and without prior WLE.
RESULTS: Of the 1395 patients identified, 104 had WLE before LM/SLNB. The mean preoperative WLE radial margin was 1.4 cm (median, 1.0 cm). LM/SLNB was successful in 103 of 104 (99%) patients. Age, tumor thickness, incidence of ulceration, and incidence of SLN positivity in the group with prior WLE were similar to those of the cohort of patients who had concomitant LM/SLNB and WLE (n = 1291). In 97 (93%) of the 104 prior-WLE patients, the surgical defects were closed by either primary closure or skin graft; 7 patients (7%) had rotational flaps. The median follow-up of these 104 patients was 51 months. Among the prior-WLE group, 19 patients (18%) had a positive SLNB; of these 19 patients, 4 (21%) had recurrences (3 distant failures and 1 local and distant failure). There were no lymph node recurrences-in a mapped or unmapped basin-in these 104 patients with a negative or positive SLNB.
CONCLUSIONS: SLNs can be successfully identified and accurately reflect the status of the regional lymph node basin in carefully selected melanoma patients with a previous WLE. Prior WLE does not appear to adversely impact the ability to detect lymphatic metastases, although the utility of LM/SLNB in patients who have undergone extensive reconstruction of the primary excision site remains to be defined. Because more extensive surgery may be required to accomplish accurate lymph node staging in patients who have undergone prior WLE-including the possible removal of SLNs from additional lymph node basins and an additional surgical procedure-to minimize morbidity and cost, concomitant WLE and LM/SLNB is strongly preferred whenever possible. (c) 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 17063497     DOI: 10.1002/cncr.22320

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

3.  Sentinel lymph node biopsy following a rotational flap.

Authors:  Adam K Brys; Michelle M Schneider; M Angelica Selim; Paul J Mosca
Journal:  BMJ Case Rep       Date:  2015-07-14

4.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

5.  Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions.

Authors:  Evan S Glazer; Caitlin F Porubsky; Jeffrey D Francis; Jamie Ibanez; Nicholas Castner; Jane L Messina; Amod A Sarnaik; Michael A Harrington; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

6.  Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.

Authors:  Jonathan S Zager; Steven N Hochwald; Suroosh S Marzban; Rony Francois; Kimberly M Law; Ashley H Davis; Jane L Messina; Vladimir Vincek; Christina Mitchell; Ann Church; Edward M Copeland; Vernon K Sondak; Stephen R Grobmyer
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

Review 7.  Surgical Management of Melanoma: Advances and Updates.

Authors:  Juan A Santamaria-Barria; Joshua M V Mammen
Journal:  Curr Oncol Rep       Date:  2022-06-03       Impact factor: 5.075

8.  Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

Authors:  F C Wright; L H Souter; S Kellett; A Easson; C Murray; J Toye; D McCready; C Nessim; D Ghazarian; N J Look Hong; S Johnson; D P Goldstein; T Petrella
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 9.  Controversies in the diagnosis and treatment of early cutaneous melanoma.

Authors:  O A Orzan; A Șandru; C R Jecan
Journal:  J Med Life       Date:  2015 Apr-Jun

Review 10.  Staging of cutaneous melanoma.

Authors:  P Mohr; A M M Eggermont; A Hauschild; A Buzaid
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.